Executive function predicts response to antiaggression treatment in schizophrenia: A randomized controlled trial

Journal of Clinical Psychiatry

Volumn 73, Issue 1, 2012, Pages 74-80

  Krakowski, Menahem I ^a,b   Czobor, Pal ^a,c  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CLOZAPINE; HALOPERIDOL; OLANZAPINE; SERENIC AGENT;

ADULT; ADVERSE OUTCOME; AGGRESSION; ANTICHOLINERGIC SYNDROME; ARTICLE; BEHAVIOR DISORDER; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MECHANISM; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84856301116     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07238     Document Type: Article

References (36)

1. Lelliott P, Wing J, Clifford P. A national audit of new long-stay psychiatric patients, 1: method and description of the cohort. Br J Psychiatry. 1994;165(2):160-169. doi:10.192/bjp.165.2.160 PubMed
2. Bigelow DA, Cutler DL, Moore LJ, et al. Characteristics of state hospital patients who are hard to place. Hosp Community Psychiatry. 1988;39(2):181-185. PubMed
3. Greenfield TK, McNiel DE, Binder RL. Violent behavior and length of psychiatric hospitalization. Hosp Community Psychiatry. 1989;40(8):809-814. PubMed
4. Wilson WH, Claussen AM. 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Psychiatr Serv. 1995;46(4):386-389. PubMed
5. Volavka J, Zito JM, Vitrai J, et al. Clozapine effects on hostility and aggression in schizophrenia. J Clin Psychopharmacol. 1993;13(4): 287-289. doi:10.1097/04714-193080-012 PubMed (Pubitemid 23265171)
6. Giancola PR. Neuropsychological functioning and antisocial behavior: Implications for etiology and prevention. In: Fishbein D, ed. The Science, Treatment and Prevention of Antisocial Behavior. Kingston, NJ: Civic Research Institute; 2000:111-116.
7. Morgan AB, Lilienfeld SO. A meta-analytic review of the relation between antisocial behavior and neuropsychological measures of executive function. Clin Psychol Rev. 2000;20(1):113-136. doi:10.1016/S0272-7358(98)096-8 PubMed (Pubitemid 30038232)
8. Luria A. Higher Cortical Functions in Man. New York, NY: Basic Books; 1980.
9. Sprague J, Verona E, Kalkhoff W, et al. Moderators and mediators of the stress-aggression relationship: executive function and state anger. Emotion. 2011;11(1):61-73. doi:10.1037/a02178 PubMed
10. Lau MA, Pihl RO, Peterson JB. Provocation, acute alcohol intoxication, cognitive performance, and aggression. J Abnorm Psychol. 1995;104(1):150-155. doi:10.1037/021-843X.104.1.150 PubMed
11. Lysaker PH, Bell MD, Bioty SM. Cognitive deficits in schizophrenia: Prediction of symptom change for participators in work rehabilitation. J Nerv Ment Dis. 1995;183(5):332-336. doi:10.1097/05053-195050-010 PubMed
12. Velligan DI, Bow-Thomas CC, Mahurin RK, et al. Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? J Nerv Ment Dis. 2000;188(8):518-524. doi:10.1097/05053-2080-07 PubMed
13. Evans JD, Bond GR, Meyer PS, et al. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophr Res. 2004;70(2-3):331-342. doi:10.1016/j.schres.204.01.01 PubMed (Pubitemid 39141110)
14. Smith RC, Largen J, Vroulis G, et al. Neuropsychological test scores and clinical response to neuroleptic drugs in schizophrenic patients. Compr Psychiatry. 1992;33(2):139-145. doi:10.1016/010-40X(92)9012-F PubMed
15. Chen EY, Hui CL, Dunn EL, et al. A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients. Schizophr Res. 2005;77(1):99-104. doi:10.1016/j.schres.205.02.020 PubMed (Pubitemid 40957065)
16. Nolan KA, Czobor P, Roy BB, et al. Characteristics of assaultive behavior among psychiatric inpatients. Psychiatr Serv. 2003;54(7):1012-1016. doi:10.176/api.ps.54.7.1012 PubMed (Pubitemid 36793456)
17. Kay SR, Wolkenfeld F, Murrill LM. Profiles of aggression among psychiatric patients, 1: nature and prevalence. J Nerv Ment Dis. 1988;176(9):539-546. doi:10.1097/05053-198090-07 PubMed
18. Berg EA. A simple objective test for measuring flexibility in thinking. J Gen Psychol. 1948;39(1):15-22.
19. Radford LM, Chaney EF, O'Leary MR, et al. Screening for cognitive impairment among inpatients. J Clin Psychiatry. 1978;39(9):712-715. PubMed
20. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 2nd ed. Tucson, AZ: Neuropsychology Press; 1993.
21. Tiffin J, Asher EJ. The Purdue Pegboard; norms and studies of reliability and validity. J Appl Psychol. 1948;32(3):234-247. doi:10.1037/h06126 PubMed
22. Wechsler D. The Wechsler Memory Scale. 3rd ed. San Antonio, TX: Psychological Corporation (Harcourt); 1997.
23. Wechsler D. The Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: Psychological Corporation (Harcourt); 1997.
24. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. PubMed
25. Chouinard G, Ross-Chouinard A, Annable L, et al. Extrapyramidal Symptom Rrating Scale. Can J Neurol Sci. 1980;7:233-239.
26. Honigfeld G, Gillis RD, Klett CJ. NOSIE-30: a treatment-sensitive ward behavior scale. Psychol Rep. 1966;19(1):180-182. doi:10.246/pr0.196.19.1.180 PubMed
27. Krakowski MI, Czobor P, Citrome L, et al. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2006;63(6):622-629. doi:10.101/archpsyc.63.6.62 PubMed (Pubitemid 43848293)
28. Wilder-Willis KE, Shear PK, Steffen JJ, et al. The relationship between cognitive dysfunction and coping abilities in schizophrenia. Schizophr Res. 2002;55(3):259-267. doi:10.1016/S0920-964(01)021-0 PubMed (Pubitemid 34607380)
29. Brower MC, Price BH. Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: a critical review. J Neurol Neurosurg Psychiatry. 2001;71(6):720-726. doi:10.136/jnp.71.6.720 PubMed (Pubitemid 33121911)
30. Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation: a possible prelude to violence. Science. 2000;289(5479):591-594. doi:10.126/science.289.5479.591 PubMed (Pubitemid 30622056)
31. Chiodo LA, Bunney BS. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci. 1985;5(9):2539-2544. PubMed
32. Bergqvist PBF, Dong J, Blier P. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study. Psychopharmacology (Berl). 1999;143(1):89-96. doi:10.107/s0213050923 PubMed (Pubitemid 29189999)
33. Sánchez C, Arnt J, Hyttel J, et al. The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice. Psychopharmacology (Berl). 1993;110(1-2):53-59. doi:10.107/BF0246950 PubMed (Pubitemid 23029427)
34. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989;46(7):587-599. PubMed
35. Smith DE, King MB, Hoebel BG. Lateral hypothalamic control of killing: evidence for a cholinoceptive mechanism. Science. 1970;167(3919):900-901. doi:10.126/science.167.3919.90 PubMed
36. Swartz MS, Swanson JW, Hiday VA, et al. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry. 1998;155(2):226-231. PubMed